Current Opinion in Nephrology and Hypertension

Article	Citations
Population Health Strategies for Health Equity in Chronic Kidney Disease Management: Retraction	37
Dual organ transplantation: Pancreas and Liver in the kidney axis	35
Emerging strategies to reduce kidney function decline and improve cardiovascular outcomes	30
Editorial introductions	25
Does cooled dialysate still have a role in reducing intradialytic stress? Implications of the MyTEMP trial	24
Tackling the intersectoral challenges in kidney diseases and transplantation: shared decision and realistic care for advanced diagnostic and therapeutic modalities for kidney diseases and transplantat	24
Effect of the allelic background on the phenotype of primary hyperoxaluria type I	23
Barriers to home dialysis and kidney transplantation for socially disadvantaged individuals	23
Interferon gamma in the pathogenesis of hypertension − recent insights	23
The impact of conflicts on patients with chronic kidney disease	20
Medical nutrition therapy using plant-focused low-protein meal plans for management of chronic kidney disease in diabetes	20
Maximizing opportunities for kidney transplantation in older adults	19
Editorial introduction	18
The coronavirus disease 2019 pandemic: the disruptor that maintenance dialysis never anticipated	18
International equity in access to home dialysis	17
Prediction models for earlier stages of chronic kidney disease	17
Reconciling Systolic Blood Pressure Intervention Trial with Eighth Joint National Commission: a nuanced view of optimal hypertension control in the chronic kidney disease population	17
Renal denervation for the treatment of hypertension and kidney disease	16
Modern indications for referral for kidney and pancreas transplantation	16
Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?	15
Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD	15
Recent advances in peritoneal dialysis catheter placement: the association between method of insertion, operator, and prior abdominal surgery and outcomes	15
Bringing the end-stage kidney disease life plan home	15
Staying home when peritoneal dialysis ends: the integrated home dialysis approach	14
Plant-based diets for kidney disease prevention and treatment	14

Sodium phosphate cotransporter 2a inhibitors: potential therapeutic uses	13
The race coefficient in glomerular filtration rate-estimating equations and its removal	13
Calcium-binding protein 39 in with-no-lysine kinase signaling and the modulation of renal tubular transport	13
Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease	12
Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression	12
Dialysis initiation for patients with decompensated cirrhosis when liver transplant is unlikely	12
Synergistic susceptibility to environmental lead toxicity in chronic kidney disease	11
Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future	11
Editorial: The evolution of my personal conflict of interest: I am part of an ‘ineligible company’	11
Built environment and chronic kidney disease: current state and future directions	11
Editorial: One size does not fit all: moving toward individualized therapy	11
Understanding renal phosphate handling: unfinished business	10
Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension	10
A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?	10
Bringing medical education “home”: the university health network and St. Michael's hospital home dialysis fellowship	10
Combination therapy with kidney protective therapies: optimizing the benefits?	10
Complement detection in kidney biopsies – utility and challenges	10
Editorial introductions	10
A current update of the development of Chimeric Antigen Receptor T-cell therapy and kidney disease	9
When the earth shakes unexpectedly: impact on nephrology services and patients	9
Lipocalin-2: a novel link between the injured kidney and the bone	9
Kidney dysfunction requiring dialysis is a heterogeneous syndrome: we should treat it like one	9
Automation and innovation in home hemodialysis machines	9
Climate change and kidney stones	9
Dietary protein intake and plant-dominant diets to mitigate risk of allograft dysfunction progression in kidney transplant recipients	9
Cancer drugs and acute kidney injury: new therapies and new challenges	9
Editorial: Advancements in the management of kidney disease and electrolyte derangements	9
A guide for program development of environmentally sustainable kidney care	9
HIV-associated kidney disease: the changing spectrum and treatment priorities	8
Deep learning applications for kidney histology analysis	8
New and old approaches to nutritional management of acute and chronic glomerulonephritis	8
Recent updates in kidney risk prediction modeling: novel approaches and earlier outcomes	8
Editorial: Innovations in multimodal and integrated approaches in kidney care and renal transplantation	8
Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease	8
Evolving thresholds for the diagnosis of acute T cell mediated rejection	8
Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism	8
Impact of intensive blood pressure control on kidney outcomes	8
The current therapeutic approach for anaemia after kidney transplant	8
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond	8
Vaccination in kidney disease: what did we learn from COVID-19 pandemic	7
Sex differences in renal electrolyte transport	7
Editorial introduction	7
Recent advances in treatment options for kidney disease	7
Hypernatremia in the intensive care unit	7
Prospects for gene therapy in polycystic kidney disease	7
Editorial introductions	7
Editorial introductions	7
Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays	7
New insights into renal calcium-sensing receptor activation	7
Epithelial Na+ channel and the glycocalyx: a sweet and salty relationship for arterial shear stress sensing	7

Renal osteodystrophy: something old, something new, something needed	7
Building kidney organoids from pluripotent stem cells	6
Evolving indications and management patterns in heart – kidney transplantation	6
Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis	6
Novel approaches in antihypertensive pharmacotherapeutics	6
Prevention of postoperative acute kidney injury: insights from recent clinical trials	6
Renal denervation: recent developments in clinical and preclinical research	6
Multimodal approaches for inequality in kidney care: turning social determinants of health into opportunities	6
Novel intestinal dialysis interventions and microbiome modulation to control uremia	6
Therapies in autosomal dominant polycystic kidney disease: beyond tolvaptan	6
New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease	6
Screening for chronic kidney disease: change of perspective and novel developments	6
Contemporary risk prediction models in chronic kidney disease: when less is more	6
The genetics of cystinuria – an update and critical reevaluation	6
Proximal tubule responses to injury: interrogation by single-cell transcriptomics	6
Population health strategies for health equity in chronic kidney disease management	5
Cystatin C should be routinely available for estimating kidney function	5
Effects of aging on chronic kidney disease mineral and bone disorder	5
Chronic kidney disease and sex dimorphism	5
New therapeutics for primary hyperoxaluria type 1	5
New guidelines and therapeutic updates for the management of lupus nephritis	5
The potential of artificial intelligence-based applications in kidney pathology	5
An update on corticosteroid treatment for IgA nephropathy	5
The role of calprotectin in vascular calcification	5
Frailty, multimorbidity and sarcopaenia in haemodialysis patients	5
Adverse effects during treatment with renin–angiotensin–aldosterone system inhibitors; should we stay or should we stop?	5
Peritoneal dialysis and heart failure	5
Novel agents for treating IgA nephropathy	5
Fibroblast growth factor 23 as a risk factor for incident diabetes	5
Editorial introductions	5
The changing trajectory of diabetic kidney disease	5
Exercise as a therapeutic intervention in chronic kidney disease: are we nearly there yet?	5
Targeting inflammation in hypertension	5
Editorial: Novel therapeutic approaches in chronic kidney disease and kidney transplantation: the draw of evolving integrated multimodal approaches in the targeted therapy era	5
Role of inwardly rectifying K+ channel 5.1 (Kir5.1) in the regulation of renal membrane transport	4
Editorial: Narrow the gap, build a bridge: an inspirational approach to chronic kidney disease–mineral and bone disorder	4
Editorial introductions	4
Updates on renal phosphate transport	4
Fibroblast growth factor 23, klotho and heparin	4
Indications for and results of renal autotransplantation	4
Agents to treat osteoporosis in chronic kidney disease	4
Updated diagnostic and therapeutic management for membranous nephropathy	4
Fifty years of basic and clinical renal stone research: have we achieved major breakthroughs? A debate	4
Electrolytes disturbances in cancer patients	4
WNK1 in the kidney	4
Postnatal renal tubule development: roles of tubular flow and flux	4
Glomerular filtration rate and sexual dimorphism: lessons from animal and human studies	4
The times they are K+-changin’: bringing the potassium curriculum out of the 20th century	4
Pruritus in chronic kidney disease	4
Use of water in dialysis and its impact on the environment	4
Climate crisis and nephrology: a review of climate change's impact on nephrology and how to combat it	4
Diagnostic and therapeutic challenges in implementing hypertension management after kidney transplantation	4
The role of osteopontin in chronic kidney disease-mineral bone disorder	4
Mendelian randomization and the association of fibroblast growth factor-23 with heart failure with preserved ejection fraction	4
Climate change and its influence in nephron mass	4
COVID-19 in patients with glomerular disease	4
The promise of artificial intelligence for kidney pathophysiology	4
Progress in the management of patients with diabetes and chronic kidney disease	4
Centering marginalized voices in advocacy for equitable policy change in kidney disease	4
Factors that lead to dialysis as the preferred treatment modality for patients with chronic kidney disease	4
Literature review: are NSAIDs harmful and is acetaminophen well tolerated?	4
Phosphate sensing in health and disease	4
Home dialysis: there's no place like home	4
Editorial introductions	4
Insights into proliferative glomerulonephritis with monoclonal immunoglobulin deposits – is it really monoclonal or not?	4
Mitochondrial deacetylase Sirt3 in vascular dysfunction and hypertension	4
Implications of climate change on acute kidney injury	3
Applications of cardiac biomarkers in chronic kidney disease	3
Revisiting the relationship between (Pro)Renin receptor and the intrarenal RAS: focus on the soluble receptor	3
APOL1 nephropathy – a population genetics success story	3
Heating up: climate change and the threat to human health	3
Recent advances in the understanding of the peritoneal membrane	3
Cellular and molecular interrogation of kidney biopsy specimens	3
Targeting aldosterone to improve cardiorenal outcomes: from nonsteroidal mineralocorticoid receptor antagonists to aldosterone synthase inhibitors	3
Community acquired and hospital acquired AKI - two diseases divided by a common definition	3
Novel insights in the regulation of intercalated cell differentiation	3
Management of antineutrophil cytoplasmic antibody-associated vasculitis: a changing tide	3
Editorial introductions	3
Let's stop talking about ‘citrate toxicity’	3
Editorial introductions	3

Lysine and salt-sensitive hypertension	3
Current status of the assessment of sarcopenia, frailty, physical performance and functional status in chronic kidney disease patients	3
Uromodulin: more than a marker for chronic kidney disease progression	3
Challenges and advances in the management of antineutrophil cytoplasmic antibody vasculitis in 2025	3
Justifying access to kidney care in low resource and humanitarian settings	3
The genetic spectrum of Gitelman(-like) syndromes	3
Skin autofluorescence as tool for cardiovascular and diabetes risk prediction	3
Role of artificial intelligence in the diagnosis and management of kidney disease: applications to chronic kidney disease and acute kidney injury	3
Persistent hyperparathyroidism in long-term kidney transplantation: time to consider a less aggressive approach	3
Novel approach to unpleasant symptom clusters surrounding pruritus in patients with chronic kidney disease and on dialysis therapy	3
Kidney health and function with left ventricular assist devices	3
SLC26A1 directs sulfate homeostasis in health and disease	3
Oh, My Gut! New insights on the role of the gastrointestinal tract and the gut microbiome in chronic kidney disease-mineral and bone disorder	3
Biopsy-based transcriptomics in the diagnosis of kidney transplant rejection	3
Contribution of phosphate and FGF23 to CKD progression	3
APOL1-associated kidney disease: modulators of the genotype-phenotype relationship	3
Novel pharmacological interventions for diabetic kidney disease	3
Social and humanitarian issues in nephrology and hypertension	3
Editorial introductions	3
Challenges in standardizing preimplantation kidney biopsy assessments and the potential of AI-Driven solutions	3
Mitochondrial DNA – novel mechanisms of kidney damage and potential biomarker	3
Editorial introductions	3